Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



ISCP September 2019 newsletter available online

Posted on April 04, 2019

Latest newsletter including message from ISCP President Augusto Gallino and more ISCP news and upcoming meetings. more

COMPASS: Low-dose rivaroxaban plus aspirin confers reduced embolic stroke risk

Posted on September 17, 2019

According to new data from the COMPASS trial, patients with systemic atherosclerosis assigned low-dose rivaroxaban plus aspirin had reduced risk for cardioembolic... more

TRI-REPAIR: Valve reconstruction system reduces tricuspid regurgitation at 1 year

Posted on September 17, 2019

PHILADELPHIA — The success of a transcatheter tricuspid valve reconstruction system in patients with tricuspid regurgitation was maintained at 1 year, researchers... more

LV end-diastolic pressure significant marker for outcomes after heart catheterization

Posted on September 17, 2019

PHILADELPHIA — Following left heart catheterization, offloading measured by left ventricular end-diastolic pressure was a notable marker for worse HF hospitalization-free survival... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •  Augusto Gallino


    Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX (more…) more

  •  Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  •  Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  •  Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more